PatientsVille.com Logo

PatientsVille

Gastro Side Effects

Common Gastro Side Effects


The most commonly reported Gastro side effects (click to view or check a box to report):

Diarrhoea (7)
Cardio-respiratory Arrest (4)
Aspiration (4)
Decreased Appetite (4)
Vomiting (4)
Rash (4)
Anaemia (3)
Loss Of Consciousness (3)
Unresponsive To Stimuli (3)
Blood Creatinine Increased (3)
Pyrexia (3)
Dizziness (3)
Posture Abnormal (2)
Acute Respiratory Distress Syndrome (2)
Renal Failure Acute (2)
Abdominal Pain (2)
Faecal Incontinence (2)
Blood Bilirubin Increased (2)
Swelling Face (2)
Renal Tubular Necrosis (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Gastro Side Effects Reported to FDA

The following Gastro reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Gastro on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Acute Respiratory Distress Syndrome, Pneumonia Aspiration
This is a report of a 32-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: x-ray with contrast upper gastrointestinal tract, who was treated with Gastrografin (dosage: NA, start time: NS), combined with:
  • Oxygen (Via Nasal Cannula)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Acute Respiratory Distress Syndrome
  • Pneumonia Aspiration
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gastrografin treatment in female patients, resulting in acute respiratory distress syndrome side effect. The patient was hospitalized.

Loss Of Consciousness, Diarrhoea, Faecal Incontinence, Urinary Incontinence, Vomiting
This report suggests a potential Gastrografin Loss Of Consciousness, Diarrhoea, Faecal Incontinence, Urinary Incontinence, Vomiting side effect(s) that can have serious consequences. A female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: x-ray with contrast upper gastrointestinal tract and used Gastrografin (dosage: 1 Bottle) starting Jan 16, 2012. Soon after starting Gastrografin the patient began experiencing various side effects, including:
  • Loss Of Consciousness
  • Diarrhoea
  • Faecal Incontinence
  • Urinary Incontinence
  • Vomiting
Drugs used concurrently:
  • Acyclovir (800 Mg In Am And 800 Mg In Pm)
  • Atenolol (25 Mg In Am And 25 Mg In Pm)
  • Pepcid Ac (20 Mg In Am And 20 Mg In Pm)
  • Advil
  • Alprazolam
  • Benadryl (As Needed)
  • Mometasone Furoate (0.1% Cream)
The patient was hospitalized. Although Gastrografin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as loss of consciousness, may still occur.

Loss Of Consciousness, Vomiting, Faecal Incontinence
This Loss Of Consciousness, Vomiting, Faecal Incontinence problem was reported by a consumer or non-health professional from US. A 62-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: gastrointestinal scan. On Jan 16, 2012 this consumer started treatment with Gastrografin Meglamine Sodium (dosage: One Bottle Once I Drank It.). The following drugs were being taken at the same time: NA. When commencing Gastrografin Meglamine Sodium, the patient experienced the following unwanted symptoms/side effects:
  • Loss Of Consciousness
  • Vomiting
  • Faecal Incontinence
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as loss of consciousness, may become evident only after a product is in use by the general population.

Rash, Swelling Face
This is a report of a 52-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Gastrografin (dosage: NA) starting Jun 16, 2012. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Rash
  • Swelling Face
The patient was hospitalized. This opens a possibility that Gastrografin treatment could cause the above reactions, including rash, and some female subjects may be more susceptible.


Fall, Pathological Fracture, Humerus Fracture, Chondroma, Dyspepsia, Pancreatitis Acute
A 74-year-old female patient (weight: NA) from US with the following symptoms/conditions: NA started Gastrograffin treatment (dosage: One Gallon) on Aug 08, 2010. Soon after starting Gastrograffin treatment, the subject experienced various side effects, including:
  • Fall
  • Pathological Fracture
  • Humerus Fracture
  • Chondroma
  • Dyspepsia
  • Pancreatitis Acute
Concurrently used drugs:
  • Inderal
  • Hydrochlorothiazide
  • Glyburide
  • Paracetamol
This finding indicates that some female patients could be more vulnerable to Gastrograffin.

Blood Creatinine Increased, Blood Uric Acid Increased, Loss Of Consciousness, Blood Urea Increased, Anaemia, Decreased Appetite, Pyrexia
A 67-year-old female patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Gastrom(dosage: NA). The treatment was initiated on Apr 11, 2012. After that a consumer reported the following side effect(s):
  • Blood Creatinine Increased
  • Blood Uric Acid Increased
  • Loss Of Consciousness
  • Blood Urea Increased
  • Anaemia
  • Decreased Appetite
  • Pyrexia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Gastrom efficacy:
  • Peg-intron (1.5 Mcg/kg;qw;sc, 0.9 Mcg/kg;qw;sc)
  • Peg-intron (1.5 Mcg/kg;qw;sc, 0.9 Mcg/kg;qw;sc)
  • Pravastatin Sodium
  • Voltaren
  • Magmit
  • Telavic (antivirals Nos) (2250 Mg;qd;po, 1500 Mg;qd;po, 1000 Mg;qd;po)
  • Telavic (antivirals Nos) (2250 Mg;qd;po, 1500 Mg;qd;po, 1000 Mg;qd;po)
  • Telavic (antivirals Nos) (2250 Mg;qd;po, 1500 Mg;qd;po, 1000 Mg;qd;po)
The patient was hospitalized.

Anaemia
In this report, Gastrom was administered for the following condition: NA.A 89-year-old female consumer from JAPAN (weight: NA) started Gastrom treatment (dosage: NA) on Nov 05, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Anaemia
A possible interaction with other drugs could have contributed to this reaction:
  • Aldactone
  • Actos
  • Aspara K
  • Januvia
  • Urso 250
  • Prednisolone
  • Amaryl
  • Novolin R (4-6u)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Gastrom treatment could be related to the listed above side effect(s).

Weight Increased, Acne, Liver Function Test Abnormal
This is a report of the following Gastrozepin side effect(s):
  • Weight Increased
  • Acne
  • Liver Function Test Abnormal
A female patient from GERMANY (weight: NA) presented with the following condition: NA and received a treatment with Gastrozepin (dosage: NA) starting: Jan 01, 2011.The following concurrently used drugs could have generated interactions:
  • Lorazepam (Unk Ukn, Unk)
  • Fluoxetine (Unk Ukn, Unk)
  • Solian (Unk Ukn, Unk)
  • Clozapine
  • Risperdal (Unk Ukn, Unk)
  • Isotrexin (Unk Ukn, Unk)
  • Duac (Unk Ukn, Unk)
This report suggests that a Gastrozepin treatment could be associated with the listed above side effect(s).

Aspiration
This Gastrografin report was submitted by a 34-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: x-ray,oesophageal perforation and Gastrografin was administered (dosage: NA) starting: Mar 26, 2012. The consumer developed a set of symptoms:
  • Aspiration
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Gastrografin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Inappropriate Antidiuretic Hormone Secretion
This is a report of a possible correlation between Gastrom use and the following symptoms/side effect(s):
  • Inappropriate Antidiuretic Hormone Secretion
which could contribute to an assessment of Gastrom risk profile.A female consumer from JAPAN (weight: NA) was suffering from NA and was treated with Gastrom (dosage: NA) starting Dec 01, 2011.Other concurrent medications:
  • Olmesartan Medoxomil
  • Depas
  • Lucentis (Left Eye)
  • Sitagliptin Phosphate
  • Zetia
  • Lucentis (Right Eye)
  • Indapamide
  • Doxazosin Mesylate
The patient was hospitalized.

Aspiration
A 34-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: oesophageal perforation,x-ray and after a treatment with Gastrografin (dosage: NA) experienced the following side effect(s):
  • Aspiration
The treatment was started on Mar 26, 2012. Gastrografin was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Gastrografin consumers.

Hepatic Failure, Hepatitis, Malaise, Blood Bilirubin Increased, Bilirubin Conjugated Increased, Somnolence, Ascites, Dermatitis, Epstein-barr Virus Antibody Positive
In this report, a 81-year-old female patient from JAPAN (weight: NA) was affected by a possible Gastrom side effect.The patient was diagnosed with NA. After a treatment with Gastrom (dosage: Unk, start date: Nov 10, 2011), the patient experienced the following side effect(s):
  • Hepatic Failure
  • Hepatitis
  • Malaise
  • Blood Bilirubin Increased
  • Bilirubin Conjugated Increased
  • Somnolence
  • Ascites
  • Dermatitis
  • Epstein-barr Virus Antibody Positive
The following simultaneously used drugs could have led to this reaction:
  • Celestamine Tab (2 Df, 1x/day)
  • Lansoprazole (Unk)
  • Atarax (25 Mg, 1x/day)
  • Olopatadine Hcl (5 Mg, 1x/day)
  • Xyzal (5 Mg, 1x/day)
  • Bezalip
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Gastrom treatment.

Angina Unstable
This is a report of a 82-year-old male patient from JAPAN (weight: NA), who used Gastrom (dosage: NA) for a treatment of NA. After starting a treatment on Nov 12, 2011, the patient experienced the following side effect(s):
  • Angina Unstable
The following drugs could possibly have interacted with the Gastrom treatment
  • Celectol
  • Isosorbide Dinitrate
  • Januvia
  • Warfarin Potassium
  • Guanabenz Acetate
  • Losartan Potassium And Hydrochlorothiazide
  • Warfarin Potassium
  • Aspirin
The patient was hospitalized.Taken together, these observations suggest that a Gastrom treatment could be related to side effect(s), such as Angina Unstable.

Platelet Count Decreased, Thrombocytopenic Purpura
This platelet count decreased side effect was reported by a physician from JAPAN. A 79-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Gastrom (dosage: NA), which was started on NS. Concurrently used drugs:
  • Cefazolin Sodium
  • Zantac
When starting to take Gastrom the consumer reported the following symptoms:
  • Platelet Count Decreased
  • Thrombocytopenic Purpura
These side effects may potentially be related to Gastrom.

Palmar-plantar Erythrodysaesthesia Syndrome
This is a Gastrom side effect report of a female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: gastritis, who was treated with Gastrom (dosage:3g Per Day, start time: Apr 17, 2010), combined with:
  • Rabeprazole Sodium (10mg Per Day)
  • Tykerb (1250mg Per Day)
  • Lipitor (10mg Per Day)
  • Rize (10mg Per Day)
  • Methycobal (1500mg Per Day)
  • Xeloda (1800mg Per Day)
  • Etodolac (400mg Per Day)
, and developed a serious reaction and a palmar-plantar erythrodysaesthesia syndrome side effect. The patient presented with:
  • Palmar-plantar Erythrodysaesthesia Syndrome
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Gastrom treatment in female patients suffering from gastritis, resulting in palmar-plantar erythrodysaesthesia syndrome.

Urticaria, Chest Pain
This report suggests a potential Gastrografin urticaria side effect(s) that can have serious consequences. A 48-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): NA and used Gastrografin (dosage: NA) starting Dec 28, 2010. Soon after starting Gastrografin the patient began experiencing various side effects, including:
  • Urticaria
  • Chest Pain
Drugs used concurrently:
  • Ultravist 150 (120 Ml, Once)
Although Gastrografin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as urticaria, may still occur.

Balance Disorder, Hypoaesthesia, Multiple Sclerosis, Amaurosis
This balance disorder problem was reported by a physician from PORTUGAL. A female patient (weight: NA) was diagnosed with the following medical condition(s): dyspnoea,crohn's disease,depression.On Jan 01, 2009 a consumer started treatment with Gastroliber (dosage: NA). The following drugs/medications were being taken at the same time:
  • Mesalamine
  • Escitalopram
  • Humira
When commencing Gastroliber, the patient experienced the following unwanted symptoms /side effects:
  • Balance Disorder
  • Hypoaesthesia
  • Multiple Sclerosis
  • Amaurosis
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as balance disorder, may become evident only after a product is in use by the general population.

Rash, Jaundice, Dysphonia, Hypophosphataemia, Decreased Appetite, Hepatic Encephalopathy, Lipase Increased, Alopecia, Hepatic Neoplasm Malignant
This is a Gastrom side effect report of a 74-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Gastrom (dosage: Since Before Administration) starting Mar 10, 2010. Concurrently used drugs:
  • Ts 1 (Daily Dose 300 Mg)
  • Nexavar (400 Mg (daily Dose), , Oral)
  • Aspirin (Since Before Administration)
  • Interferon Alfa (500 Miu, Tiw)
  • Etoposide (Daily Dose 100 Mg)
  • Nexavar (800 Mg (daily Dose), , Oral)
  • Nexavar (Daily Dose 400 Mg)
  • Depas (Since Before Administration)
Soon after that, the consumer experienced the following of symptoms:
  • Rash
  • Jaundice
  • Dysphonia
  • Hypophosphataemia
  • Decreased Appetite
  • Hepatic Encephalopathy
  • Lipase Increased
  • Alopecia
  • Hepatic Neoplasm Malignant
The patient was hospitalized. This opens a possibility that Gastrom could cause rash and that some male patients may be more susceptible.

Blood Glucose Increased, Carotid Artery Stenosis, Blood Pressure Systolic Increased, Reflux Oesophagitis, Glycosylated Haemoglobin Increased, Interstitial Lung Disease, Rhinitis, Hepatic Steatosis, Hiatus Hernia
A 77-year-old male patient (weight: NA) from JAPAN with the following symptoms: NA started Gastrom (ecabet Monosodium) treatment (dosage: NA) on Jul 19, 2003. Soon after starting Gastrom (ecabet Monosodium) treatment, the consumer experienced several side effects, including:
  • Blood Glucose Increased
  • Carotid Artery Stenosis
  • Blood Pressure Systolic Increased
  • Reflux Oesophagitis
  • Glycosylated Haemoglobin Increased
  • Interstitial Lung Disease
  • Rhinitis
  • Hepatic Steatosis
  • Hiatus Hernia
. Concurrently used drugs:
  • Irbetan (irbesartan)
  • Amlodipine Besylate
  • Irbesartan
  • Actos (15 Mg (15 Mg, 1 In 1 D) 30 Mg (30 Mg, 1 D) 15 Mg (15 Mg, 1 In 1 D))
  • Actos (15 Mg (15 Mg, 1 In 1 D) 30 Mg (30 Mg, 1 D) 15 Mg (15 Mg, 1 In 1 D))
  • Actos (15 Mg (15 Mg, 1 In 1 D) 30 Mg (30 Mg, 1 D) 15 Mg (15 Mg, 1 In 1 D))
  • Lantus
  • Doxazosin Mesylate
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Gastrom (ecabet Monosodium) side effects, such as blood glucose increased.

Product Quality Issue, Product Odour Abnormal
This product quality issue side effect was reported by a health professional from UNITED STATES. A 61-year-old female patient (weight:NA) experienced the following symptoms/conditions: x-ray.The patient was prescribed Gastrografin (dosage: 20ml Once Other), which was started on Mar 15, 2011. Concurrently used drugs: NA..When starting to take Gastrografin the consumer reported symptoms, such as:
  • Product Quality Issue
  • Product Odour Abnormal
These side effects may potentially be related to Gastrografin.

Platelet Count Decreased, Hepatic Failure, Blood Bilirubin Increased, Ascites
This is a report of a male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Gastrom (dosage: Daily Dose 3 Df, start time: Jan 01, 1998), combined with:
  • Takepron (Daily Dose 1 Df)
  • Protecadin (Daily Dose 2 Df)
  • Uncodeable ^unclassifiable^ (Daily Dose 3 Df)
  • Nexavar (400 Mg, Qd)
  • Eviprostat (Daily Dose 1 Df)
  • Nexavar (200 Mg, Qd)
  • Flivas (Daily Dose 1 Df)
  • Amlodipine (Daily Dose 1 Df)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Platelet Count Decreased
  • Hepatic Failure
  • Blood Bilirubin Increased
  • Ascites
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gastrom treatment in male patients, resulting in platelet count decreased side effect. The patient was hospitalized.

Prinzmetal Angina, Alanine Aminotransferase Increased
This report suggests a potential Gastro-stop Prinzmetal Angina, Alanine Aminotransferase Increased side effect(s) that can have serious consequences. A 55-year-old female patient (weight: NA) from CANADA was diagnosed with the following symptoms/conditions: diarrhoea,colorectal cancer metastatic,back pain and used Gastro-stop (dosage: NA) starting Jan 01, 2005. Soon after starting Gastro-stop the patient began experiencing various side effects, including:
  • Prinzmetal Angina
  • Alanine Aminotransferase Increased
Drugs used concurrently:
  • Cetuximab (Weeks:22,last Dose Prior To 31mar10 Is 24mar10)
  • Oxycontin
  • Brivanib Alaninate (Weeks:22 Last Dose Prior To 31mar10 Is 23mar10)
  • Endone
The patient was hospitalized. Although Gastro-stop demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as prinzmetal angina, may still occur.

Frustration, Impaired Driving Ability, Middle Insomnia, Impaired Work Ability, Fatigue, Dizziness, Product Substitution Issue
This Frustration, Impaired Driving Ability, Middle Insomnia, Impaired Work Ability, Fatigue, Dizziness, Product Substitution Issue problem was reported by a consumer or non-health professional from UNITED STATES. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 27, 2011 this consumer started treatment with Gastrocrom (dosage: NA). The following drugs were being taken at the same time:
  • Hydrocodone Bitartrate
  • Miralax
  • Zolpidem Tartrate (12.5 Mg Once Daily 047-oral)
  • Vivelle Dot Estradiol Patch
When commencing Gastrocrom, the patient experienced the following unwanted symptoms/side effects:
  • Frustration
  • Impaired Driving Ability
  • Middle Insomnia
  • Impaired Work Ability
  • Fatigue
  • Dizziness
  • Product Substitution Issue
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as frustration, may become evident only after a product is in use by the general population.

Anaemia, Decreased Appetite, Renal Impairment, Rash, Neutrophil Count Decreased, Colorectal Cancer, Hypercalcaemia, Stomatitis
This is a report of a 75-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Gastrom (dosage: Unk Unk, Unk) starting Jul 20, 2010. Concurrently used drugs:
  • Aloxi
  • Protecadin
  • Fluorouracil (2500 Mg, Q2wk)
  • Ulcerlmin (Unk Unk, Unk)
  • Promac D (Unk Unk, Unk)
  • Protecadin (Unk Unk, Unk)
  • Fluorouracil (450 Mg, Q2wk)
Soon after that, the consumer experienced the following side effects:
  • Anaemia
  • Decreased Appetite
  • Renal Impairment
  • Rash
  • Neutrophil Count Decreased
  • Colorectal Cancer
  • Hypercalcaemia
  • Stomatitis
The patient was hospitalized. This opens a possibility that Gastrom treatment could cause the above reactions, including anaemia, and some female subjects may be more susceptible.

Dizziness, Vision Blurred
A 58-year-old male patient (weight: NA) from GERMANY with the following symptoms/conditions: NA started Gastrosil treatment (dosage: NA) on Feb 09, 2006. Soon after starting Gastrosil treatment, the subject experienced various side effects, including:
  • Dizziness
  • Vision Blurred
Concurrently used drugs:
  • Norvasc
  • Metohexal
  • Sunitinib Malate (50 Mg, 1x/day)
  • Pantozol
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Gastrosil.

1 of 3 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Gastro Side Effects

    Did You Have a Gastro Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Gastro for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Gastro Safety Alerts, Active Ingredients, Usage Information

    NDC0019-4816
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameMD-GASTROVIEW
    Namediatrizoate meglumine and diatrizoate sodium
    Dosage FormSOLUTION
    RouteORAL; RECTAL
    On market since20090831
    LabelerMallinckrodt Inc.
    Active Ingredient(s)DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
    Strength(s)600; 100
    Unit(s)mg/mL; mg/mL
    Pharma ClassRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-

    More About Gastro

    Side Effects reported to FDA: 55

    Gastro safety alerts: No

    Reported deaths: 10

    Reported hospitalizations: 12

    Latest Gastro clinical trials